A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

Condition:   IgA Nephropathy and Focal Segmental Glomerulosclerosis Interventions:   Drug: HS-10390 tablet;   Drug: Placebo tablet Sponsor:   Hansoh BioMedical R&D  Company Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials